Filing Details

Accession Number:
0001373604-24-000028
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-16 08:58:26
Reporting Period:
2024-05-14
Accepted Time:
2024-05-16 08:58:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1637715 Reneo Pharmaceuticals Inc. RPHM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1373603 Michael Braden Leonard 65 E Cedar - Suite 2
Zionsville IN 46077
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-14 79,281 $1.56 2,337,194 No 4 P Indirect Holding of BML Investment Partners, L.P.
Common Stock Acquisiton 2024-05-14 335,000 $1.54 2,672,194 No 4 P Indirect Holding of BML Investment Partners, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Holding of BML Investment Partners, L.P.
No 4 P Indirect Holding of BML Investment Partners, L.P.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,020,769 Direct
Footnotes
  1. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
  2. Purchased in multiple transactions with a weighted average price of $1.56. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
  3. Purchased in multiple transactions with a weighted average price of $1.54. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.